Skip to main content
GlaxoSmithKline Consumer Healthcare logo

GlaxoSmithKline Consumer Healthcare — Investor Relations & Filings

Ticker · GSKCH ISIN · PK0112101016 LEI · 549300QZEWI02JKJJW94 PSX Manufacturing
Filings indexed 173 across all filing types
Latest filing 2023-01-06 Regulatory Filings
Country GB United Kingdom
Listing PSX GSKCH

About GlaxoSmithKline Consumer Healthcare

http://www.haleon.pk/

GlaxoSmithKline Consumer Healthcare has demerged to become Haleon, an independent consumer healthcare company. Haleon is dedicated to improving everyday health by empowering individuals through self-care. The company develops and delivers category-leading brands, emphasizing innovation and trusted science. Its comprehensive product portfolio includes Oral Health solutions, addressing concerns such as sensitivity and bleeding gums, alongside offerings in Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals and Supplements (VMS). Haleon's mission is to provide accessible, science-backed solutions that enable consumers globally to proactively manage their health and well-being.

Recent filings

Filing Released Lang Actions
Approval of Company Name Change - Haleon Pakistan Limited
Regulatory Filings
2023-01-06 English
Results of the Board of Directors Meeting Other than Financial Results
Regulatory Filings
2022-12-05 English
CTC of Special Resolutions Passed in the Extraordinary General Meeting 2022
Regulatory Filings
2022-12-05 English
Notice of Board Meeting Other Than Financial Results
Regulatory Filings
2022-11-25 English
Notice of Extraordinary General Meeting - 2022
Regulatory Filings
2022-11-14 English
Prior Publication of Extraordinary General Meeting Notice - 2022
Regulatory Filings
2022-11-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.